Open Access
Issue |
J Oral Med Oral Surg
Volume 30, Number 4, 2024
|
|
---|---|---|
Article Number | 27 | |
Number of page(s) | 6 | |
DOI | https://doi.org/10.1051/mbcb/2024036 | |
Published online | 16 December 2024 |
- Montes-Moreno S, Leoncini L, Miranda R, Louissaint JA, Sengar M. Plasmablastic lymphoma. In: Ott G, Jong D, Dave SS, editors. WHO Classification of Haematolymphoid Tumours (Online), Lyon: International Agency for Research on Cancer, 2022. https://tumourclassification.iarc.who.int/chaptercontent/63/154 (Accessed on 30th January 2024) [Google Scholar]
- Leoncini L, Siebert R, Ferry JA, Boy S. Plasmablastic lymphoma. In: Khoury JD, Chan JKC, editors. WHO Classification of the Head and Neck Tumours (Online), Lyon: International Agency for Research on Cancer, 2022. https://tumourclassification.iarc.who.int/chaptercontent/52/244 (Accessed on 30th January 2024) [Google Scholar]
- Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997;89:1413–1420. [CrossRef] [PubMed] [Google Scholar]
- Medeiros LJ, Ferry JA, Martinez LQ. Diffuse large B-cell lymphoma. In: Khoury JD, Chan JKC, editors. WHO Classification of the Head and Neck Tumours (Online), Lyon: International Agency for Research on Cancer, 2022. https://tumourclassification.iarc.who.int/chaptercontent/52/242. (Accessed on 21st June 2024) [Google Scholar]
- Rodrigues-Fernandes CI, de Souza LL, Santos-Costa SFD, Pontes HAR, de Almeida OP, Vargas PA, et al. Clinicopathological analysis of oral diffuse large B-cell lymphoma, NOS: A systematic review. J Oral Pathol Med 2019;48:185–191. [CrossRef] [PubMed] [Google Scholar]
- Montes-Moreno S, Gonzalez-Medina AR, Rodriguez-Pinilla SM, Maestre L, Sanchez-Verde L, Roncador G, et al. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterisation of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype. Haematologica 2010;95:1342–1349. [CrossRef] [PubMed] [Google Scholar]
- Bailly J, Jenkins N, Chetty D, Mohamed Z, Verburgh ER, Opie JJ. Plasmablastic lymphoma: An update. Int J Lab Hematol 2022;44:54–63. Erratum in: Int J Lab Hematol 2022;44:1121. [CrossRef] [PubMed] [Google Scholar]
- Valera A, Colomo L, Martínez A, de Jong D, Balague O, Matheu G, et al. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol 2013;26:1329–1337. [Google Scholar]
- Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 2014;38:875–886. [CrossRef] [PubMed] [Google Scholar]
- Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993; 22:289–91. [CrossRef] [PubMed] [Google Scholar]
- Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood 2015;125:2323–30. [CrossRef] [PubMed] [Google Scholar]
- Castillo JJ, Furman M, Beltrán BE, Bibas M, Bower M, Chen W, et al. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 2012;118:5270–5277. [CrossRef] [PubMed] [Google Scholar]
- Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma 2010;51:2047–53. [CrossRef] [PubMed] [Google Scholar]
- Vaughan J, Perner Y, Mayne E, Wiggill T. Plasmablastic lymphoma in Johannesburg, South Africa, in the era of widescale antiretroviral therapy use. HIV Med 2021;22:225–30. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.